Helmerich & Payne, Inc. To Participate in Conferences in September 2024

Helmerich & Payne, Inc. (NYSE: HP) today announced that John Lindsay, President and Chief Executive Officer; Kevin Vann, Senior Vice President and Chief Financial Officer; Trey Adams, Senior Vice President of Digital Operations, Sales, and Marketing; and Dave Wilson, Vice President of Investor Relations plan to participate in the following investor conferences during the month of September 2024. Participation by the management team will vary by event.

  • Barclays 38th Annual CEO Energy-Power Conference on Wednesday and Thursday, September 4-5, 2024; Mr. Lindsay will participate in a panel discussion on behalf of the Company on Wednesday, September 4, 2024 at 11:30 a.m. U.S. ET.
  • Pickering Energy Partners 4th Annual Energy Conference on Tuesday and Wednesday, September 17-18, 2024

Investor slides to be used during the conferences are available for download on the company’s website, within Investors, under Presentations.

About Helmerich & Payne, Inc.

Founded in 1920, Helmerich & Payne, Inc. is committed to delivering industry leading drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for our customers and returns for shareholders. Through its subsidiaries, the Company designs, fabricates and operates high-performance drilling rigs in conventional and unconventional plays around the world. H&P also develops and implements advanced automation, directional drilling and survey management technologies. For more information, visit www.helmerichpayne.com.

Helmerich & Payne uses its website as a channel of distribution for material company information. Such information is routinely posted and accessible on its Investor Relations website at www.helmerichpayne.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.